{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:42:58Z","timestamp":1791614578074,"version":"4.3.4"},"reference-count":154,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.mycmed.2020.100949","type":"journal-article","created":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T02:48:33Z","timestamp":1584154113000},"page":"100949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Treatment and management strategies of onychomycosis"],"prefix":"10.1016","volume":"30","author":[{"given":"R.","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Targhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.K.","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.K.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2020.100949_bib0775","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/myc.12537","article-title":"Epidemiology of onychomycosis in Serbia: a laboratory-based survey and risk factor identification","volume":"60","author":"Dubljanin","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2020.100949_bib0780","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/jdv.13677","article-title":"The prevalence of unsuspected onychomycosis and its causative organisms in a multicentre Canadian sample of 30,000 patients visiting physicians\u2019 offices","volume":"30","author":"Gupta","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0785","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/myc.12533","article-title":"Epidemiology of onychomycosis in Crete: Greece: a 12-year study","volume":"59","author":"Maraki","year":"2016","journal-title":"Mycoses"},{"issue":"7\u20138","key":"10.1016\/j.mycmed.2020.100949_bib0790","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11046-016-0014-7","article-title":"Genotyping and in vitro antifungal susceptibility testing of fusarium isolates from onychomycosis in India","volume":"181","author":"Gupta","year":"2016","journal-title":"Mycopathologia"},{"key":"10.1016\/j.mycmed.2020.100949_bib0795","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/myc.12448","article-title":"The prevalence of Candida onychomycosis in South eastern Serbia from 2011 to 2015","volume":"59","author":"Otasevic","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2020.100949_bib0800","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/pde.12986","article-title":"Epidemiologic analysis of onychomycosis in the San Diego pediatric population","volume":"34","author":"Totri","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0805","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1067\/mjd.2000.107754","article-title":"A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns","volume":"43","author":"Ghannoum","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0810","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1468-3083.2006.01412.x","article-title":"The epidemiology of onychomycoses in Crete, Greece, between 1992 and 2001","volume":"20","author":"Ioannidou","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3\u20134","key":"10.1016\/j.mycmed.2020.100949_bib0815","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1439-0507.2004.00968.x","article-title":"Onychomycosis in Denmark: prevalence of fungal nail infection in general practice","volume":"47","author":"Svejgaard","year":"2004","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2020.100949_bib0820","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2133.1995.tb02741.x","article-title":"The prevalence of onychomycosis in Finland","volume":"133","author":"Heikkala","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0825","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/archderm.1997.03890450124022","article-title":"Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions","volume":"133","author":"Elewski","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0830","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2133.1993.tb03510.x","article-title":"The epidemiology of onychomycosis in Britain","volume":"129","author":"Williams","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0835","first-page":"230","article-title":"A double blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toenail onychomycosis","volume":"136","author":"Havu","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0840","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0019-5154.31923","article-title":"A five-year survey of onychomycosis in New Delhi, India: Epidemiological and laboratory aspects","volume":"52","author":"Kaur","year":"2007","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0845","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0190-9622(08)81256-X","article-title":"Proceedings of the international summit on cutaneous antifungal therapy and mycology workshop","volume":"31","author":"Elewski","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0850","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0190-9622(08)81269-8","article-title":"Common superficial fungal infections in immunosuppressed patients","volume":"31","author":"Odom","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0855","series-title":"Fitzpatrick's color atlas and synopsis of clinical dermatology","author":"Wolff","year":"2005"},{"key":"10.1016\/j.mycmed.2020.100949_bib0860","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1100\/tsw.2004.134","article-title":"Evaluation of the drug treatment and persistence of onychomycosis","volume":"4","author":"Campbell","year":"2004","journal-title":"Sci World J"},{"key":"10.1016\/j.mycmed.2020.100949_bib0865","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/jof1010030","article-title":"Onychomycosis: a review","volume":"1","author":"Piraccini","year":"2015","journal-title":"J Fungi"},{"key":"10.1016\/j.mycmed.2020.100949_bib0870","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/2321-4848.133811","article-title":"Fungal nail disease (onychomycosis): challenges and solutions","volume":"2","author":"Shenoy","year":"2014","journal-title":"Arch Med Heal Sci"},{"key":"10.1016\/j.mycmed.2020.100949_bib0875","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1365-2133.1998.02449.x","article-title":"A new classification of onychomycosis","volume":"139","author":"Baran","year":"1998","journal-title":"Br J Dermatology"},{"key":"10.1016\/j.mycmed.2020.100949_bib0880","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1517\/17425247.4.4.453","article-title":"1st meeting on topical drug delivery to the nail","volume":"4","author":"Murdan","year":"2007","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.mycmed.2020.100949_bib0885","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.clindermatol.2013.06.011","article-title":"Therapies for the treatment of onychomycosis","volume":"31","author":"Gupta","year":"2013","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0890","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000051643","article-title":"Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes","volume":"202","author":"Gupta","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.mycmed.2020.100949_bib0895","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/S0190-9622(08)81274-1","article-title":"Oral therapeutic agents in fungal nail disease","volume":"31","author":"Roberts","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0900","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2133.2003.05242.x","article-title":"Guidelines for treatment of onychomycosis","volume":"148","author":"Roberts","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0905","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1345\/aph.1M165","article-title":"Efficacy of fluconazole for the treatment of onychomycosis","volume":"43","author":"Brown","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.mycmed.2020.100949_bib0910","doi-asserted-by":"crossref","first-page":"551","DOI":"10.7547\/87507315-87-12-551","article-title":"Traditional approaches to treatment of onychomycosis","volume":"87","author":"Markinson","year":"1997","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.mycmed.2020.100949_bib0915","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1468-3083.2012.04584.x","article-title":"Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta-analysis of efficacy for continuous and intermittent regimens","volume":"27","author":"Gupta","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0920","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1365-2133.149.s65.1.x","article-title":"Drug synergies and the potential for combination therapy in onychomycosis","volume":"149","author":"Evans","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0925","first-page":"10","article-title":"The role of topical antifungal therapy for onychomycosis and the emergence of newer agents","volume":"7","author":"Del Rosso","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0930","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","article-title":"Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies","volume":"68","author":"Elewski","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0935","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0733-8635(03)00035-4","article-title":"The diagnosis of onychomycosis","volume":"21","author":"Mahoney","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.mycmed.2020.100949_bib0940","first-page":"203","article-title":"Efinaconazole solution 10%: topical antifungal therapy for toenail onychomycosis","volume":"92","author":"Tosti","year":"2013","journal-title":"Cutis"},{"key":"10.1016\/j.mycmed.2020.100949_bib0945","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1002\/jps.24459","article-title":"Efinaconazole topical solution 10%: Formulation development program of a new topical treatment of toenail onychomycosis","volume":"104","author":"Bhatt","year":"2015","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.mycmed.2020.100949_bib0950","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02056-12","article-title":"Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis","volume":"57","author":"Jo Siu","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2020.100949_bib0955","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1128\/AAC.00111-14","article-title":"The low keratin affinity of efinaconazole contributes to its nail penetration andfungicidal activity in topical onychomycosis treatment","volume":"58","author":"Sugiura","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2020.100949_bib0960","first-page":"1388","article-title":"Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails","volume":"13","author":"Sakamoto","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0965","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/1346-8138.14935","article-title":"Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: a multicenter, single-arm study","volume":"46","author":"Iozumi","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0970","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1517\/14656566.2014.921158","article-title":"Tavaborole for the treatment of onychomycosis","volume":"15","author":"Elewski","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.mycmed.2020.100949_bib0975","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/jps.20901","article-title":"In Vitro penetration of a novel oxaborale antifungal (AN2690) into the human nail plate","volume":"96","author":"Hui","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.mycmed.2020.100949_bib0980","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/ced.12973","article-title":"Pilot study to evaluate a plasma device in the treatment of onychomycosis","volume":"42","author":"Lipner","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0985","first-page":"AB116","article-title":"Interim results of a multi-center study to evaluate the safety and efficacy of topically applied AN2690 5.0% and 7.5% solutions for the treatment of onychomycosis of the great toenail","volume":"60","author":"Benter","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib0990","first-page":"1","article-title":"Drug delivery across human nail","volume":"1","author":"Patel","year":"2009","journal-title":"Int J Curr Pharm Res"},{"key":"10.1016\/j.mycmed.2020.100949_bib0995","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2009.10.002","article-title":"Transungual drug delivery: current status","volume":"384","author":"Elkeeb","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mycmed.2020.100949_bib1000","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ejpb.2012.11.004","article-title":"Thermo gelling hydrogels of cyclodextrin\/poloxamer polypseudorotaxanes as aqueous-based nail lacquers: application to the delivery of triamcinolone acetonide and ciclopirox olamine","volume":"83","author":"Nieto","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.mycmed.2020.100949_bib1005","series-title":"Device and method of treating fungal nail infections","author":"Gotlieb","year":"2013"},{"key":"10.1016\/j.mycmed.2020.100949_bib1010","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/myc.12592","article-title":"Understanding the formidable nail barrier: a review of the nail microstructure, composition and diseases","volume":"60","author":"Baswan","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2020.100949_bib1015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1211\/0022357991772448","article-title":"Drug permeation through the three layers of the human nail plate","volume":"51","author":"Kobayashi","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1020","series-title":"Baran & Dawber's diseases of the nails and their management","article-title":"Science of nail apparatus","author":"Dawber","year":"2001"},{"key":"10.1016\/j.mycmed.2020.100949_bib1025","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1083\/jcb.103.6.2593","article-title":"Acidic and basic hair\/nail (\u201chard\u201d) keratins: their colocalization in upper cortical and cuticlecells of the human hair follicle and their relationship to \u201csoft\u201d keratins","volume":"103","author":"Lynch","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1030","series-title":"Dermatology in general medicine","author":"Fitzpatrick","year":"1993"},{"key":"10.1016\/j.mycmed.2020.100949_bib1035","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11837-012-0302-8","article-title":"The structure, functions, and mechanical properties of keratin","volume":"64","author":"McKittrick","year":"2012","journal-title":"JOM"},{"key":"10.1016\/j.mycmed.2020.100949_bib1040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1242\/jeb.00814","article-title":"The fracture properties and mechanical design of human fingernails","volume":"207","author":"Farren","year":"2004","journal-title":"J Exp Biol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00406540","article-title":"The ultrastructure and growth of human nails","volume":"269","author":"Dawber","year":"1980","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.mycmed.2020.100949_bib1050","first-page":"363","article-title":"Structural characteristics and permeability properties of the human nail: a review","volume":"50","author":"Gupchup","year":"1999","journal-title":"Anglais"},{"key":"10.1016\/j.mycmed.2020.100949_bib1055","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijpharm.2006.09.042","article-title":"An investigation into keratinolytic enzymes to enhance ungual drug delivery","volume":"332","author":"Mohorcic","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mycmed.2020.100949_bib1060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.7326\/0003-4819-95-1-131_1","article-title":"The nail in health and disease","volume":"95","author":"Zaias","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mycmed.2020.100949_bib1065","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1046\/j.1365-2133.1996.d01-906.x","article-title":"Quantification of regional matrix nail production","volume":"134","author":"De Berker","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1070","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1365-2133.1987.tb07358.x","article-title":"Ultrasound transmission time: an in vivo guide to nail thickness","volume":"117","author":"Finlay","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/geronj\/10.4.401","article-title":"Studies of growth throughout the lifespan in Japanese: growth and size of nails and their relationship to age, sex, heredity, and other factors","volume":"10","author":"Hamilton","year":"1955","journal-title":"J Gerontol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.sder.2008.12.003","article-title":"Management of psoriatic nail disease","volume":"28","author":"Berker","year":"2009","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.mycmed.2020.100949_bib1085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00989-9","article-title":"Drug delivery to the nail following topical application","volume":"236","author":"Murdan","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mycmed.2020.100949_bib1090","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.2042-7158.1997.tb06127.x","article-title":"In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: prediction of the penetration rate of antimycotics through the nail plate and their efficacy","volume":"49","author":"Mertin","year":"1997","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1095","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/03639045.2011.637931","article-title":"Ungual and transungual drug delivery","volume":"38","author":"Shivakumar","year":"2012","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.mycmed.2020.100949_bib1100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.2042-7158.1983.tb04258.x","article-title":"Physicochemical characterisation of the human nail: permeation pattern for water and the homologous alcohols and differences with respect to the stratum corneum","volume":"35","author":"Walters","year":"1983","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1105","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ejps.2003.11.008","article-title":"In vitro permeation of several drugs through the human nail plate: relationship between physicochemical properties and nail permeability of drugs","volume":"21","author":"Kobayashi","year":"2004","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.mycmed.2020.100949_bib1110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/10837450.2014.991876","article-title":"Diffusion of uncharged solutes through human nail plate","volume":"21","author":"Baswan","year":"2016","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jps.20757","article-title":"Iontophoretic drug delivery across human nail","volume":"96","author":"Murthy","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.mycmed.2020.100949_bib1120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.2042-7158.1997.tb06747.x","article-title":"In-vitro permeability of the human nail and of a keratin membrane from bovine hooves: influence of the partition coefficient octanol\/water and the water solubility of drugs on their permeability and maximum flux","volume":"49","author":"Mertin","year":"1997","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jdermsci.2006.12.010","article-title":"Iontophoretic permselective property of human nail","volume":"46","author":"Murthy","year":"2007","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.mycmed.2020.100949_bib1130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0168-3659(00)00350-3","article-title":"Characterization of the iontophoretic permselectivity properties of human and pig skin","volume":"70","author":"Marro","year":"2001","journal-title":"J Control Release"},{"key":"10.1016\/j.mycmed.2020.100949_bib1135","first-page":"357","article-title":"Characterization of ion transport across human plate","volume":"34","author":"Baswan","year":"2012","journal-title":"Int J Cosmetic Sci"},{"key":"10.1016\/j.mycmed.2020.100949_bib1140","first-page":"252","article-title":"Drug delivery through nails: present and future","volume":"3","author":"Shanbhaga","year":"2017","journal-title":"New Horiz in Translational Med"},{"key":"10.1016\/j.mycmed.2020.100949_bib1145","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1473-2130.2004.00095.x","article-title":"Nail abrasion","volume":"2","author":"Chiacchio","year":"2003","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1150","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/2278-9596.146421","article-title":"Nail avulsion with adjuvant therapy in nail disorders","volume":"4","author":"Suthar","year":"2014","journal-title":"Arch Int Surg"},{"key":"10.1016\/j.mycmed.2020.100949_bib1155","first-page":"299","article-title":"Nail avulsion: indications and methods [surgical nail avulsion]","volume":"78","author":"Pandhi","year":"2012","journal-title":"Ind J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425240802497218","article-title":"Enhancing the nail permeability of topically applied drugs","volume":"5","author":"Murdan","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.mycmed.2020.100949_bib1165","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jps.10058","article-title":"Investigation of nail permeation enhancement by chemical modification using water as a probe","volume":"91","author":"Malhotra","year":"2002","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.mycmed.2020.100949_bib1170","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3109\/03639045.2016.1165690","article-title":"Iontophoresis for drug delivery into the nail apparatus: exploring hyponychium as the site of delivery","volume":"42","author":"Kushwaha","year":"2016","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.mycmed.2020.100949_bib1175","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1517\/14656566.2012.681779","article-title":"New therapeutic options for onychomycosis","volume":"13","author":"Gupta","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.mycmed.2020.100949_bib1180","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/jdv.12950","article-title":"An update on photodynamic therapies in the treatment of onychomycosis","volume":"29","author":"Simmons","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1185","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMcp0804878","article-title":"Clinical practice. Fungal nail disease","volume":"360","author":"Berker","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mycmed.2020.100949_bib1190","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5173(02)00321-6","article-title":"Nail morphology studies as assessments for onychomycosis treatment modalities","volume":"245","author":"Repka","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mycmed.2020.100949_bib1195","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00006534-200107000-00017","article-title":"A comprehensive review of epinephrine in the finger: to do or not to do","volume":"108","author":"Denkler","year":"2001","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.mycmed.2020.100949_bib1200","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1524-4725.1977.tb00252.x","article-title":"Avulsion of a nail plate","volume":"3","author":"Albom","year":"1977","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1205","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/09546630701243418","article-title":"Review of antifungal therapy and the severity index for assessing onychomycosis: part I","volume":"19","author":"Baran","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.mycmed.2020.100949_bib1210","first-page":"609","article-title":"Urea ointment in the nonsurgical avulsion of nail dystrophies\u00a0\u2013\u00a0a reappraisal","volume":"25","author":"South","year":"1998","journal-title":"Cutis"},{"key":"10.1016\/j.mycmed.2020.100949_bib1215","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s11095-007-9368-3","article-title":"Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers","volume":"24","author":"Khengar","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.mycmed.2020.100949_bib1220","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.2042-7158.1985.tb04966.x","article-title":"Physicochemical characterization of the human nail: solvent effects on the permeation of homologous alcohols","volume":"37","author":"Walters","year":"1985","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1225","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejps.2007.07.009","article-title":"Effect of hydration on the permeation of ketoconazole through human nail plate in vitro","volume":"32","author":"Gunt","year":"2007","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.mycmed.2020.100949_bib1230","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1002\/jps.20988","article-title":"Water diffusivity in human nail plate","volume":"96","author":"Gunt","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.mycmed.2020.100949_bib1235","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1248\/cpb.46.1797","article-title":"Enhancing effect of N-acetyl-l-cysteine or 2-mercaptoethanol on the in vitro permeation of 5-fluorouracil or tolnaftate through the human nail plate","volume":"46","author":"Kobayashi Miyamoto","year":"1998","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.mycmed.2020.100949_bib1240","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3109\/03639049809082373","article-title":"The effect of keratolytic agents on the permeability of three imidazole antimycotic drugs through the human nail","volume":"24","author":"Quintanar-Guerrero","year":"1998","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.mycmed.2020.100949_bib1245","first-page":"25","article-title":"The use of a novel ungual penetration enhancing technology. MedNail to demonstrate that disulphide bond disruption in the nail increases the permeability of three antifungal agents","author":"Khengar","year":"2008","journal-title":"Proceedings Skin Forum"},{"key":"10.1016\/j.mycmed.2020.100949_bib1250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2008.11.009","article-title":"Overcoming the nail barrier: a systematic investigation of ungual chemical penetration enhancement","volume":"370","author":"Brown","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mycmed.2020.100949_bib1255","series-title":"Percutaneous absorption: drugs-cosmetics-mechanisms-methodology","first-page":"759","article-title":"Nail penetration. Focus on topical delivery of antifungal drugs for onychomycosis treatment","author":"Sun","year":"1999"},{"key":"10.1016\/j.mycmed.2020.100949_bib1260","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2011.08.021","article-title":"Hydration and N-acetyl-l-cysteine alter the microstructure of human nail and bovine hoof: implications for drug delivery","volume":"156","author":"Nogueiras-Nieto","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.mycmed.2020.100949_bib1265","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0928-0987(97)00270-4","article-title":"Nail penetration of the antifungal agent oxiconazole after repeated topical application in healthy volunteers, and the effect of acetylcysteine","volume":"5","author":"Van Hoogdalem","year":"1997","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.mycmed.2020.100949_bib1270","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2008.01.027","article-title":"Chemical method to enhance transungual transport and iontophoresis efficiency","volume":"357","author":"Hao","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mycmed.2020.100949_bib1275","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1002\/jps.21711","article-title":"Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis","volume":"98","author":"Nair","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.mycmed.2020.100949_bib1280","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/jps.23139","article-title":"Iontophoresis across the proximal nail fold to target drugs to the nail matrix","volume":"1","author":"Manda","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.mycmed.2020.100949_bib1285","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3109\/03639045.2014.927481","article-title":"Trans-ungual delivery of itraconazole hydrochloride by iontophoresis","volume":"41","author":"Kushwaha","year":"2015","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.mycmed.2020.100949_bib1290","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/lsm.1136","article-title":"Extended theory of selective photothermolysis","volume":"29","author":"Altshuler","year":"2001","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.mycmed.2020.100949_bib1295","series-title":"Iontophoretic application of terbinafine gel to the large toe nail","author":"Transport Pharmaceuticals","year":"2009"},{"key":"10.1016\/j.mycmed.2020.100949_bib1300","series-title":"Deposition of terbinafine after iontophoretic application of ets terbinafine gel in subjects with distal subungual onychomycosis in the great toenail","author":"Nitric BioTherapeutics, Inc.","year":"2012"},{"key":"10.1016\/j.mycmed.2020.100949_bib1305","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2133.2009.09414.x","article-title":"Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study","volume":"162","author":"Amichai","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1310","first-page":"4","article-title":"Device-based therapies for onychomycosis treatment","volume":"17","author":"Gupta","year":"2012","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.mycmed.2020.100949_bib1315","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.6836297","article-title":"Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation","volume":"220","author":"Anderson","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.mycmed.2020.100949_bib1320","first-page":"S07","article-title":"Summary: clearsteps\u00a0\u2013\u00a0laser onychomycosis treatment: assessment of efficacy 12 months after treatment and beyond","volume":"2011","author":"Kozarev","year":"2011","journal-title":"J Laser Health Acad"},{"key":"10.1016\/j.mycmed.2020.100949_bib1325","first-page":"1","article-title":"Novel laser therapy in treatment of onychomycosis","volume":"1","author":"Kozarev","year":"2010","journal-title":"J Laser Health Acad"},{"key":"10.1016\/j.mycmed.2020.100949_bib1330","series-title":"Joule ClearSense, Sciton, Inc.","author":"FDA 510(k) Summary K111483","year":"2011"},{"key":"10.1016\/j.mycmed.2020.100949_bib1335","series-title":"PinPointe FootLaser, PinPointe USA, Inc.","author":"FDA 510(k) Summary K093547","year":"2010"},{"key":"10.1016\/j.mycmed.2020.100949_bib1340","first-page":"1","article-title":"Laser treatment for toenail fungus","volume":"71610","author":"Harris","year":"2009","journal-title":"Proc SPIE"},{"key":"10.1016\/j.mycmed.2020.100949_bib1345","series-title":"Cutera GenesisPlus Laser System, Cutera, Inc.","author":"FDA 510(k) Summary K103626","year":"2010"},{"key":"10.1016\/j.mycmed.2020.100949_bib1350","series-title":"3 Month Clinical Results using Sub-Millisecond 1064nm Nd:YAG Laser for the Treatment of Onychomycosis","author":"Weiss","year":"2011"},{"key":"10.1016\/j.mycmed.2020.100949_bib1355","series-title":"CoolBreeze Features","author":"CoolTouch Inc.","year":"2011"},{"key":"10.1016\/j.mycmed.2020.100949_bib1360","series-title":"Q-Clear, Light Age, Inc.","author":"FDA 510(k) Summary K110370","year":"2011"},{"key":"10.1016\/j.mycmed.2020.100949_bib1365","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10103-007-0492-4","article-title":"The effects of laser irradiation on trichophyton rubrum growth","volume":"23","author":"Vural","year":"2008","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.mycmed.2020.100949_bib1370","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/14764172.2011.552616","article-title":"Laser treatment of onychomycosis using a novel 0.65- millisecond pulsed Nd:YAG 1064-nm laser","volume":"13","author":"Hochman","year":"2011","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.mycmed.2020.100949_bib1375","series-title":"Introducing the Sciton ClearSense Accessory featuring the ClearToe treatment for Onychomycosis (For Non-U.S. Customers)","author":"Waibel","year":"2011"},{"key":"10.1016\/j.mycmed.2020.100949_bib1380","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1751-1097.2009.00672.x","article-title":"Direct antifungal effect of femtosecond laser on trichophyton rubrum onychomycosis","volume":"86","author":"Manevitch","year":"2010","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1385","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1751-1097.2009.00615.x","article-title":"Near-infrared photoinactivation of bacteria and fungi at physiologic temperatures","volume":"85","author":"Bornstein","year":"2009","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1390","doi-asserted-by":"crossref","first-page":"166","DOI":"10.7547\/1000166","article-title":"Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure","volume":"100","author":"Landsman","year":"2010","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/j.mycmed.2020.100949_bib1395","series-title":"Highlights in Skin Cancer","article-title":"Photodynamic therapy for non-melanoma skin cancer","author":"Andrade","year":"2013"},{"key":"10.1016\/j.mycmed.2020.100949_bib1400","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archdermatol.2007.17","article-title":"Successful treatment of toenail onychomycosis with photodynamic therapy","volume":"144","author":"Watanabe","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1405","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/med.20251","article-title":"Photodynamic therapy based on 5-aminolevulinic acid and its use as an antimicrobial agent","volume":"32","author":"Harris","year":"2012","journal-title":"Med Res Rev"},{"key":"10.1016\/j.mycmed.2020.100949_bib1410","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jaad.2010.06.008","article-title":"Treatment of refractory fingernail onychomycosis caused by nondermatophyte molds with methylaminolevulinate photodynamic therapy","volume":"65","author":"Gilaberte","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1415","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1562\/0031-8655(2003)077<0556:PIOTDT>2.0.CO;2","article-title":"Photodynamic inactivation of the dermatophyte Trichophyton rubrum","volume":"77","author":"Smijs","year":"2003","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1420","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1751-1097.2008.00468.x","article-title":"Preclinical studies with 5,10,15-Tris(4- methylpyridinium)-20-phenyl- [21H,23H]-porphine trichloride for the photodynamic treatment of superficial mycoses caused by Trichophyton rubrum","volume":"85","author":"Smijs","year":"2009","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1425","first-page":"S2","article-title":"Influence of etching and ultrasound on the permeability of ciclopirox through the human nail","volume":"8","author":"Mididoddi","year":"2006","journal-title":"AAPS"},{"key":"10.1016\/j.mycmed.2020.100949_bib1430","series-title":"Method of treating nail fungus onychomycosis","author":"Dawson","year":"2016"},{"key":"10.1016\/j.mycmed.2020.100949_bib1435","series-title":"Method and device to inactivate and kill cells and organisms that are undesirable","author":"Cumbie","year":"2018"},{"key":"10.1016\/j.mycmed.2020.100949_bib1440","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/pharmaceutics10040273","article-title":"Effect of penetration enhancers on drug nail permeability from cyclodextrin\/poloxamer-soluble polypseudorotaxane-based nail lacquers","volume":"10","author":"G\u00f3mez","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mycmed.2020.100949_bib1445","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.3109\/10717544.2015.1099059","article-title":"Novel nail penetration enhancer containing vesicles nPEVs for treatment of onychomycosis","volume":"23","author":"Bseiso","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.mycmed.2020.100949_bib1450","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1155\/2014\/950358","article-title":"Hydroxypropyl-\u03b2-cyclodextrin: a novel transungual permeation enhancer for development of topical drug delivery system for onychomycosis","volume":"2014","author":"Chouhan","year":"2014","journal-title":"J Drug Delivery"},{"key":"10.1016\/j.mycmed.2020.100949_bib1455","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/13543784.2016.1142529","article-title":"Novel investigational therapies for onychomycosis: an update","volume":"25","author":"Gupta","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.mycmed.2020.100949_bib1460","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1517\/13543784.2012.711315","article-title":"Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis","volume":"21","author":"Sigurgeirsson","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.mycmed.2020.100949_bib1465","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2017.11.008","article-title":"Enhancement of tioconazole ungual delivery: combining nanocapsule formulation and nail poration approaches","volume":"535","author":"Flores","year":"2018","journal-title":"Int J of Pharmaceutics"},{"key":"10.1016\/j.mycmed.2020.100949_bib1470","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijpharm.2017.08.115","article-title":"Voriconazole-loaded nanostructured lipid carriers (NLC) for drug delivery in deeper regions of the nail plate","volume":"531","author":"Rocha","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.mycmed.2020.100949_bib1475","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1208\/s12249-016-0528-9","article-title":"Terbinafine hydrochloride trans-ungual delivery via nanovesicular systems: in vitro characterization and ex vivo evaluation","volume":"18","author":"Elsherif","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.mycmed.2020.100949_bib1480","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1208\/s12249-016-0488-0","article-title":"Transungual delivery of ketoconazole nanoemulgel for the effective management of onychomycosis","volume":"17","author":"Mahtab","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.mycmed.2020.100949_bib1485","first-page":"e16","article-title":"Over-the-counter and natural remedies for onychomycosis: do they really work?","volume":"98","author":"Halteh","year":"2016","journal-title":"Cutis"},{"key":"10.1016\/j.mycmed.2020.100949_bib1490","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1365-4362.1997.00349.x","article-title":"Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists\u2019 offices in Ontario, Canada\u2013a multicenter survey of 2001 patients","volume":"36","author":"Gupta","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1495","doi-asserted-by":"crossref","DOI":"10.3949\/ccjm.70.2.110","article-title":"Fungal nail infection: assessing the new treatment options","volume":"70","author":"Botek","year":"2003","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.mycmed.2020.100949_bib1500","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1468-3083.2000.00124.x","article-title":"The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease","volume":"14","author":"Gupta","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1505","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2133.1998.02464.x","article-title":"Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey","volume":"139","author":"Gupta","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1510","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(97)80215-0","article-title":"Onychomycosis in children: prevalence and treatment strategies","volume":"36","author":"Gupta","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1515","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-2133.149.s65.5.x","article-title":"Onychomycosis in clinical practice: factors contributing to recurrence","volume":"149","author":"Scher","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1520","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jaad.2016.01.008","article-title":"The role of biofilms in onychomycosis","volume":"74","author":"Gupta","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.mycmed.2020.100949_bib1525","first-page":"237","article-title":"Molecular analysis of dermatophytes suggests spread of infection among household members","volume":"91","author":"Ghannoum","year":"2013","journal-title":"Cutis"},{"key":"10.1016\/j.mycmed.2020.100949_bib1530","first-page":"309","article-title":"Optimization of an infected shoe model for the evaluation of an ultraviolet shoe sanitizer device","volume":"102","author":"Ghannoum","year":"2012","journal-title":"J American Pod Med Ass"},{"key":"10.1016\/j.mycmed.2020.100949_bib1535","series-title":"Transport of Charged and Uncharged Solutes in Hydrated Human Nail Plate","author":"Sudhir","year":"2014"},{"key":"10.1016\/j.mycmed.2020.100949_bib1540","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.xphs.2015.12.011","article-title":"Size and charge dependence of ion transport in human nail plate","volume":"105","author":"Baswan","year":"2016","journal-title":"J Pharm Sci"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523320300457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523320300457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:20:47Z","timestamp":1761110447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523320300457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":154,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1156523320300457"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2020.100949","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment and management strategies of onychomycosis","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2020.100949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100949"}}